key: cord-0931271-wax5sqwp
authors: Blaurock, Claudia; Breithaupt, Angele; Weber, Saskia; Wylezich, Claudia; Keller, Markus; Mohl, Björn-Patrick; Görlich, Dirk; Groschup, Martin H.; Sadeghi, Balal; Höper, Dirk; Mettenleiter, Thomas C.; Balkema-Buschmann, Anne
title: Compellingly high SARS-CoV-2 susceptibility of Golden Syrian hamsters suggests multiple zoonotic infections of pet hamsters during the COVID-19 pandemic
date: 2022-04-20
journal: bioRxiv
DOI: 10.1101/2022.04.19.488826
sha: 2962e7979457c260f3421d46dfd9b7b10831f21e
doc_id: 931271
cord_uid: wax5sqwp

Golden Syrian hamsters (Mesocricetus auratus) are used as a research model for severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). Millions of Golden Syrian hamsters are also kept as pets in close contact to humans. To determine the minimum infective dose (MID) for assessing the zoonotic transmission risk, and to define the optimal infection dose for experimental studies, we orotracheally inoculated hamsters with SARS-CoV-2 doses from 1*105 to 1*10−4 tissue culture infectious dose 50 (TCID50). Body weight and virus shedding were monitored daily. 1*10−3 TCID50 was defined as the MID, and this was still sufficient to induce virus shedding at levels up to 102.75 TCID50/ml, equaling the estimated MID for humans. Virological and histological data revealed 1*102 TCID50 as the optimal dose for experimental infections. This compellingly high susceptibility resulting in productive infections in Golden Syrian hamsters needs to be considered also as a source of SARS-CoV-2 infections in humans.

controls. Pneumonia-associated consolidation was consistently found in all hamsters 136 infected with 1*10 -1 TCID50 SARS-CoV-2 or higher (Fig. 3 C, D) . Lungs collected at 10 137 dpi mainly showed regenerative changes with bronchial and type-2-pneumoncyte 138 hyperplasia and hypertrophy with formation of multinucleated, atypical cells. However, still 139 a moderate to severe inflammatory reaction was found, with intra-alveolar, interstitial, 140 peribronchial and perivascular inflammatory infiltrates, as well as vasculitis and/or 141 endothelialitis. Acute necrosis of the bronchial epithelium was a rare finding ( Fig. 4 A -C) . 142 Although not statistically significant, hamsters infected with 1*10 -1 TCID50 showed a 143 tendency to be less severely affected (Fig. 4 E) . In general, animals infected with doses of 144 1*10 -2 TCID50 and lower did not develop pneumonia-associated consolidation in the lung 145 (Fig. 4 F Lateral flow device Rapid Test detects infections with 1*10 -1 TCID50 SARS-CoV-2 150 We analysed oral swab samples collected at 6 dpi using the Nowcheck COVID-19 Rapid 151 Test, which confirmed the infection in hamsters inoculated with doses higher than 1*10 0 152 TCID50, as well as in two hamsters inoculated with 1*10 -1 TCID50, which translates into 153 samples with ct-values in the real-time RT-PCR below 30. All uninfected hamsters as well 154 as one hamster inoculated with 1*10 -1 TCID50 were negative at 6 dpi ( Fig. S1 ). We also 155 analysed nasal washes collected at 7 dpi Again, the infection was detectable in animals 156 challenged with doses of 1*10 -1 TCID50 or higher, i.e. for samples with ct-values below 30.

infected with doses of 1*10 -1 TCID50 or higher shed virus (Fig. 5 A) . The oral swab samples 170 contained replicating virus even in the groups infected with a dose of 10 -1 TCID50 until 6 171 dpi, and at a level of 10 2 TCID50 / ml in the swab sample collected at 6 dpi from one animal 172 infected with the 1*10 -3 TCID50 dose. This result was confirmed by the detection of SARS- 173 CoV-2 sgRNA as an additional proof of a present or past virus replication. All positive 174 results for the nasal wash samples collected at 2 and 4 dpi were confirmed by re-testing for 175 sgRNA, with ct values of about 3 points above those determined for the SARS-CoV-2 N-176 gene (Tab. 2). The peak of oral shedding of replication competent virus was observed 177 between 3 and 5 dpi, at levels reaching up to 10 3 TCID50 / ml in the oral swab samples (Fig   178   5 B) . 179 SARS-CoV-2 RNA levels detected in the nasal washes were generally 10-to100-times 180 higher than those determined from the oral swab samples. We were able to detect viral RNA 181 at 2 and 4 dpi in nasal washes, even in the animals infected with the lowest dose of 10 -4 182 TCID50 ( Fig. 6 A). Significant differences were determined for the copy numbers detected 183 in the different infection groups (Tab 1). The peak of nasal shedding of replication 184 competent virus was observed at 2 dpi at levels reaching up to 10 7 TCID50 / ml, while 185 1*10 2.75 TCID50 (equivalent to the estimated MID for humans), as well as sgRNA were 186 detected in a sample collected from one animal infected with 10 -3 TCID50 (Fig. 6 B) . The 187 dose-dependent delay in onset of oral and nasal shedding is summarized in Fig. 7 . at 7 dpi, independent of the inoculation dose, including the group infected with a dose of 193 1*10 -3 TCID50 ( Fig. 8 A) , while at 10 dpi, viral RNA was only detected in the samples 194 collected from the infection groups 1*10 2 to 1*10 -1 TCID50 (Fig. 8 B) . Interestingly at 7 dpi, Sequence analysis of SARS-CoV-2 retrieved from animals infected with a high or a low dose 206 We exemplarily analysed SARS-CoV-2 whole-genome sequences retrieved from nasal 207 conchae samples of two animals. Animal H310 (L5497) from a high-dose infection study 208 (1*10 4,5 TCID50) autopsied at 10 dpi, whereas animal H318 (L5537) was infected with 1*10 -209 1 TCID50. Both animals and was sacrificed at 10 dpi. The sequence of the first sample is In our study, we were able to show that an infection dose of 1*10 -1 TCID50 was sufficient 232 to induce a significant weight loss, oral and nasal shedding as well as accumulation of respiratory tract. Infection doses of 1*10 -2 TCID50 or higher were sufficient to induce a 237 dose-dependent seroconversion within 7 days, therefore the virus must have reached the In summary, we determined the extremely high susceptibility of Golden Syrian hamsters to 299 a SARS-CoV-2 infection, and defined the MID as 1*10 -3 TCID50. A very close monitoring 300 of pet Golden Syrian hamsters that are kept in households with COVID-19 patients is 301 therefore strongly recommended, for instance by using rapid tests. COVID-19 patients 302 should strictly avoid any direct or indirect contact to their pet hamsters. The optimal 303 infection dose for drug efficacy studies was determined as 1*10 2 TCID50. These conclusions 304 not only apply to Golden Syrian hamsters, but likely also to Chinese hamsters (Cricetulus 305 griseus) and Roborovski Dwarf hamsters (Phodopus roborovskii), since these two species 306 have been shown to also be highly susceptible (Bertzbach et al., 2021; Trimpert et al., 2020) . First, hamsters were inoculated with a dose of 1*10 5 TCID50 SARS-CoV-2 and with serial 363 dilutions from 1*10 3 to 1*10 -1 TCID50. Oral swab samples were collected at 1, 3, 5, and 6 364 dpi, nasal washes were collected at 2 and 4 dpi as described above. At 7 dpi, hamsters were 365 euthanized and sampled as described above. 366 In the second study, hamsters were inoculated with a serial dilution from 1*10 4 to 1*10 -3 367 TCID50 SARS-CoV-2. Sampling and autopsies were performed as described above. 368 In the third study, hamsters were inoculated with 1*10 2 TCID50, and with serial dilutions 369 from 1*10 0 to 1*10 -4 TCID50 SARS-CoV-2. This experiment was conducted for 10 days to 370 allow the follow-up of clinical and virological data after a 2 -3 day delayed disease onset 371 in the groups inoculated with low doses. Oral swab samples were collected at 1, 3, 5, 6, 8 and 9 dpi, while nasal washes were collected at 2, 4 and 7 dpi. At 10 dpi, animals were 373 sacrificed and autopsied as described above. showing vasculitis (arrow), type 2 pneumocyte hyperplasia and bronchialisation of alveoli (arrowhead), intra-alveolar 493 erythrocytes (asterisk), (iii) after 1*10 2 TCID50 infection, with vasculitis (arrow), type 2 pneumocyte hyperplasia and 494 bronchialisation of alveoli (arrowhead) and perivascular infiltrates (asterisk), (iv) after 1*10 0 TCID50 infection 495 exhibiting perivascular (arrow) and alveolar (asterisk) infiltrates, type 2 pneumocyte hyperplasia and bronchialisation 496 of alveoli (arrowhead), (v) after 1*10 -1 TCID50 infection, showing alveolar infiltrates (asterisk), type 2 pneumocyte 497 hyperplasia and bronchialisation of alveoli (arrowhead), (vi) after 1*10 -2 TCID50 infection, with focal alveolar 498 infiltrates (arrow) and edema (asterisk), (vii) after 1*10 -3 TCID50 infection, exhibiting focal hypertrophy/hyperplasia 499 of bronchial epithelium (arrow), (viii) after 1*10 -4 TCID50, with focal alveolar infiltrates (arrow), (ix) after 1*10 -4 500 TCID50 showing focal perivascular infiltrates (arrow). 501 

Group uninfected 1*10 5 TCID 50 1*10 3 TCID 50 1*10 2 TCID 50 1*10 1 TCID 50 1*10 0 TCID 50 1*10 -1 TCID 50 N  3  3  3  3  3  3  3  Ct (SD) -27,88 (2,68) 33,04 (0) 28,95 (1,65) 27,13 (4,38) 24,37 (1,53) 27,52 (1,13) TCID50 < 10 1,5 < 10 1,5 < 10 1,5 10 1,74 10 2.56 < 10 1,5 TCID50 SD 

A Versatile Sample Processing Workflow 632 for Metagenomic Pathogen Detection

Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters 636 against SARS-CoV-2 Infection

Transmission of SARS-CoV-2

Delta) from Pet Hamsters to Humans and Onward Human Propagation of the Adapted

Strain: A Case Study. The Lancet